Search

Your search keyword '"PESQUERA, R."' showing total 6 results
Start Over Author "PESQUERA, R."
6 results on '"PESQUERA, R."'

1. The use of IoT principles to reduce food waste in the kitchen

Author

Macias Pesquera, R. (author) and Macias Pesquera, R. (author)

Abstract

The aim of this graduation project was to develop a solution for the household sector capable of reducing avoidable food waste with the use of the Internet of Things. This report was initiated with an exploration of the reasons of food waste and how this problem has been, is and will continue to be addressed in relation to human actions, habits and technology. The findings were used to define a target group and a design goal. As a result, different concept directions were developed following a brainstorming session and taking as a basis a food waste avoidance model. The most achievable direction within the given time limit was selected and detailed. From this concept a prototype was designed, built and evaluated. The designed device enables households to develop positive habits to avoid food waste, specially the food that is normally wasted due to forgetfulness. It mainly provides an alternative system to the old way of labelling food, to track food freshness when expiration dates are no longer applicable, by having control of the days food has been stored at home inside the fridge. Reminders are only given when the system detects that food is danger of being forgotten., Industrial Design Engineering, Design Engineering

Published
2017

2. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration

Author

SANTAELLA, R. ALCALÁ, primary, GUARDIA, J., additional, PAJARES, J., additional, PIQUÉ, J., additional, PITA, L., additional, ALVÁREZ, E., additional, CASTELLANOS, P., additional, GUARNER, L., additional, ORTIZ, J., additional, PESQUERA, R., additional, VARGAS, V., additional, and RUIZ-CAPELLÁN, R., additional

Published
2007
Full Text
View/download PDF

5. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.

Author

Alcalá Santaella R, Guardia J, Pajares J, Pique J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J, and Pesquera R

Subjects
Adult, Anti-Ulcer Agents therapeutic use, Clinical Trials as Topic, Double-Blind Method, Drug Administration Schedule, Famotidine, Female, Humans, Male, Middle Aged, Multicenter Studies as Topic, Random Allocation, Ranitidine therapeutic use, Thiazoles therapeutic use, Anti-Ulcer Agents administration & dosage, Duodenal Ulcer drug therapy, Ranitidine administration & dosage, Thiazoles administration & dosage
Abstract

The efficacy and safety of famotidine and ranitidine in the treatment of active duodenal ulcer were compared in a multicenter, randomized double-blind study. The study was carried out at 5 centers and involved a total of 143 patients with endoscopically documented active duodenal ulcer. The patients received either famotidine (1 40 mg tablet at night) or ranitidine 2 150 mg tablets at night). Endoscopic examinations were performed at 4 and 6 weeks of active treatment. Day and nocturnal pain were also monitored, and the laboratory and clinical profiles evaluated. One hundred and thirty-three patients fulfilled the evaluation criteria (66 patients in the famotidine group and 67 in the ranitidine group). Healing rates at weeks 4 or 6 of treatment showed no significant differences between the famotidine group and the ranitidine group. The healing rates were 78% at week 4 and 96% at week 6 in the famotidine group, and 76% at week 4 and 95% at week 6 in the ranitidine group. Similar results were observed in both treatment groups with regard to pain resolution, decrease in antacid intake and safety profile.

Published
1989

6. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.

Author

Alcalá Santaella R, Guardia J, Pajares J, Piqué J, Pita L, Alvárez E, Castellanos P, Guarner L, Ortiz J, and Pesquera R

Subjects
Adult, Aged, Antacids administration & dosage, Antacids therapeutic use, Double-Blind Method, Famotidine adverse effects, Female, Humans, Male, Middle Aged, Ranitidine adverse effects, Smoking physiopathology, Duodenal Ulcer drug therapy, Famotidine therapeutic use, Ranitidine therapeutic use
Abstract

The efficacy and safety of famotidine and ranitidine in the treatment of active duodenal ulcer were compared in a multicentre, randomized, double-blind study. The study was carried out in five centres which included a total of 143 patients with endoscopically documented active duodenal ulcer. The patients received either famotidine (one tablet of 40 mg at night) or ranitidine (two tablets of 150 mg at night). Endoscopic examinations were performed at 4 and 6 weeks of active treatment. Daytime and nocturnal pain were also monitored, and the laboratory and clinical profiles evaluated. One hundred and thirty-three patients fulfilled the evaluation criteria (66 patients in the famotidine group and 67 in the ranitidine group). Healing rates at 4 or 6 weeks of treatment showed no significant differences between the famotidine and ranitidine groups. The healing rates were 80% at week 4 and 97% at week 6 in the famotidine group, and 77% at week 4 and 96% at week 6 in the ranitidine group. Similar results were observed in both treatment groups with regard to pain resolution, decrease in antacid intake and safety profile.

Published
1989
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results